CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Knell Michael Gunnar SVP, Finance and CAO | Shares withheld for taxes | −649 | $313.02 | $203K | 11,203 |
| 2026-10-22 | FOSTER JAMES C Director | Option exercise 10b5-1 | +24,042 | $244.41 | $5.9M | 55,638 |
| 2026-10-22 | FOSTER JAMES C Director | Sale 10b5-1 | −24,042 | $350.00 | $8.4M | 31,596 |
| 2026-10-22 | FOSTER JAMES C Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −24,042 | 0 | ||
| 2026-10-21 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise 10b5-1 | +2,156 | $244.41 | $527K | 6,963 |
| 2026-10-21 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Sale 10b5-1 | −2,156 | $344.41 | $743K | 4,807 |
| 2026-10-21 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,156 | 719 | ||
| 2026-10-05 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise 10b5-1 | +981 | $208.44 | $204K | 5,788 |
| 2026-10-05 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Sale 10b5-1 | −981 | $308.44 | $303K | 4,807 |
| 2026-10-05 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise · Stock Options (Right to Buy) 10b5-1 | −981 | 2,944 | ||
| 2026-09-30 | Coleman Glenn EVP & Chief Financial Officer | Purchase | +10 | $297.43 | $3K | 27,762 |
| 2026-08-25 | FOSTER JAMES C Director | Option exercise 10b5-1 | +21,132 | $194.12 | $4.1M | 52,728 |
| 2026-08-25 | FOSTER JAMES C Director | Option exercise 10b5-1 | +12,429 | $208.44 | $2.6M | 65,157 |
| 2026-08-25 | FOSTER JAMES C Director | Sale 10b5-1 | −33,561 | $300.00 | $10.1M | 31,596 |
| 2026-08-25 | FOSTER JAMES C Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −21,132 | 7,044 | ||
| 2026-08-25 | FOSTER JAMES C Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −12,429 | 12,429 | ||
| 2026-08-19 | Girshick Birgit Chief Executive Officer | Gift | −528 | 35,485 | ||
| 2026-08-19 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise 10b5-1 | +2,039 | $194.12 | $396K | 6,846 |
| 2026-08-19 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Sale 10b5-1 | −2,039 | $294.12 | $600K | 4,807 |
| 2026-08-19 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,039 | 2,039 |
Page 1 of 23 · 447 trades